focus -WSS

focus

author：hotspot 2025-09-06 04:41:02 - browse：31

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Flu, Covid vaccination rates decline, new survey data show

WSS

Key House Republican on health care plans exit from Congress

Why did Pfizer dish out millions for a Super Bowl ad?

What we’ve learned from the Aduhelm mess

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

The stability of $0 premiums in Medicare Advantage

Robert F. Kennedy is pitching centrism on health, even on abortion

hotspot

focus

leisure time

New air purifier tech could be key to improving indoor air quality

Congress extends some pandemic preparedness programs

Affirmative action in medical school literally saved lives

KalVista pill reduced swelling 'attacks' caused by genetic disease

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Hollywood unions extend contract negotiations for actors

Medicare threatens to cut off funding for HCA's Mission hospital

Activists slam private health insurers over coverage restrictions

Private equity deals in Medicare Advantage declines

focus

Congress extends some pandemic preparedness programs

Will an HIV vaccine ever be a reality?

Doctors' information doesn't help them choose wisely when sick

The United States is paying nearly triple for new Covid vaccines

For Medicare Advantage, Democrats want stronger protections around AI

Stop Congress from blocking public access to science

hotspot

knowledge

hotspot

Wikipedia